Osborne Partners Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $695K | Sell |
28,881
-79,700
| -73% | -$2.08M | 0.04% | 144 |
|
|
2026
Q1 | $3.05M | Sell |
108,581
-26,270
| -19% | -$699K | 0.16% | 112 |
|
|
2025
Q4 | $3.36M | Sell |
134,851
-52,000
| -28% | -$1.31M | 0.17% | 113 |
|
|
2025
Q3 | $4.76M | Sell |
186,851
-1,350
| -0.7% | -$33.3K | 0.24% | 101 |
|
|
2025
Q2 | $4.56M | Sell |
188,201
-2,623
| -1% | -$61.2K | 0.24% | 105 |
|
|
2025
Q1 | $4.84M | Buy |
190,824
+223
| +0.1% | +$5.83K | 0.28% | 102 |
|
|
2024
Q4 | $5.06M | Sell |
190,601
-98
| -0.1% | -$2.66K | 0.29% | 103 |
|
|
2024
Q3 | $5.52M | Buy |
190,699
+520
| +0.3% | +$15.2K | 0.31% | 97 |
|
|
2024
Q2 | $5.32M | Buy |
190,179
+9,800
| +5% | +$270K | 0.32% | 97 |
|
|
2024
Q1 | $5.01M | Sell |
180,379
-2,375
| -1% | -$65.9K | 0.31% | 99 |
|
|
2023
Q4 | $5.26M | Buy |
182,754
+48
| +0% | +$1.45K | 0.34% | 91 |
|
|
2023
Q3 | $6.06M | Sell |
182,706
-3,990
| -2% | -$141K | 0.45% | 76 |
|
|
2023
Q2 | $6.85M | Sell |
186,696
-202
| -0.1% | -$7.86K | 0.49% | 69 |
|
|
2023
Q1 | $7.63M | Buy |
186,898
+1,282
| +0.7% | +$55.4K | 0.56% | 64 |
|
|
2022
Q4 | $9.51M | Buy |
185,616
+651
| +0.4% | +$31.2K | 0.75% | 46 |
|
|
2022
Q3 | $8.09M | Sell |
184,965
-50,493
| -21% | -$2.45M | 0.68% | 53 |
|
|
2022
Q2 | $12.3M | Buy |
235,458
+197,584
| +522% | +$10.1M | 0.94% | 32 |
|
|
2022
Q1 | $1.96M | Sell |
37,874
-1,631
| -4% | -$84.6K | 0.14% | 104 |
|
|
2021
Q4 | $2.33M | Sell |
39,505
-3,297
| -8% | -$163K | 0.17% | 103 |
|
|
2021
Q3 | $1.84M | Sell |
42,802
-268
| -0.6% | -$11.9K | 0.15% | 105 |
|
|
2021
Q2 | $1.69M | Sell |
43,070
-2,630
| -6% | -$102K | 0.14% | 108 |
|
|
2021
Q1 | $1.66M | Sell |
45,700
-246,399
| -84% | -$8.75M | 0.15% | 107 |
|
|
2020
Q4 | $10.8M | Buy |
292,099
+237,914
| +439% | +$8.73M | 1.31% | 18 |
|
|
2020
Q3 | $1.89M | Sell |
54,185
-580
| -1% | -$20.3K | 0.38% | 72 |
|
|
2020
Q2 | $1.7M | Sell |
54,765
-474
| -0.9% | -$16.1K | 0.36% | 73 |
|
|
2020
Q1 | $1.71M | Sell |
55,239
-1,215
| -2% | -$41.4K | 0.45% | 68 |
|
|
2019
Q4 | $2.1M | Sell |
56,454
-527
| -0.9% | -$18.8K | 0.42% | 66 |
|
|
2019
Q3 | $1.94M | Sell |
56,981
-76
| -0.1% | -$2.76K | 0.39% | 71 |
|
|
2019
Q2 | $2.35M | Sell |
57,057
-1,581
| -3% | -$62.8K | 0.45% | 72 |
|
|
2019
Q1 | $2.36M | Sell |
58,638
-258,389
| -82% | -$10.3M | 0.46% | 68 |
|
|
2018
Q4 | $13.1M | Sell |
317,027
-1,265
| -0.4% | -$52.5K | 1.96% | 8 |
|
|
2018
Q3 | $13.3M | Buy |
318,292
+67
| +0% | +$2.58K | 1.7% | 9 |
|
|
2018
Q2 | $11M | Buy |
318,225
+1,792
| +0.6% | +$61.2K | 1.49% | 13 |
|
|
2018
Q1 | $10.7M | Sell |
316,433
-1,562
| -0.5% | -$53.7K | 1.47% | 14 |
|
|
2017
Q4 | $10.9M | Buy |
317,995
+247
| +0.1% | +$8.42K | 1.45% | 16 |
|
|
2017
Q3 | $10.8M | Sell |
317,748
-4,638
| -1% | -$149K | 1.47% | 16 |
|
|
2017
Q2 | $10.3M | Buy |
322,386
+805
| +0.3% | +$25.4K | 1.46% | 16 |
|
|
2017
Q1 | $10.4M | Sell |
321,581
-3,689
| -1% | -$116K | 1.49% | 16 |
|
|
2016
Q4 | $10M | Sell |
325,270
-168
| -0.1% | -$5.13K | 1.47% | 17 |
|
|
2016
Q3 | $10.5M | Sell |
325,438
-1,452
| -0.4% | -$48.6K | 1.57% | 15 |
|
|
2016
Q2 | $10.9M | Sell |
326,890
-2,411
| -0.7% | -$76.9K | 1.63% | 15 |
|
|
2016
Q1 | $9.26M | Sell |
329,301
-498
| -0.2% | -$14.2K | 1.36% | 18 |
|
|
2015
Q4 | $10.1M | Buy |
329,799
+597
| +0.2% | +$18.8K | 1.47% | 17 |
|
|
2015
Q3 | $9.81M | Sell |
329,202
-8,121
| -2% | -$260K | 1.44% | 20 |
|
|
2015
Q2 | $10.7M | Buy |
337,323
+429
| +0.1% | +$14K | 1.44% | 19 |
|
|
2015
Q1 | $11.1M | Sell |
336,894
-4,595
| -1% | -$146K | 1.46% | 19 |
|
|
2014
Q4 | $10.1M | Sell |
341,489
-939
| -0.3% | -$26.9K | 1.22% | 28 |
|
|
2014
Q3 | $9.61M | Sell |
342,428
-4,128
| -1% | -$116K | 1.24% | 28 |
|
|
2014
Q2 | $9.76M | Sell |
346,556
-2,430
| -0.7% | -$69.3K | 1.26% | 28 |
|
|
2014
Q1 | $10.6M | Sell |
348,986
-998
| -0.3% | -$29.8K | 1.39% | 25 |
|
|
2013
Q4 | $10.2M | Sell |
349,984
-3,610
| -1% | -$105K | 1.33% | 25 |
|
|
2013
Q3 | $9.64M | Sell |
353,594
-1,591
| -0.4% | -$43.3K | 1.34% | 24 |
|
|
2013
Q2 | $9.44M | Buy |
+355,185
| New | +$9.81M | 1.35% | 24 |
|
Other funds holding PFE
Osborne Partners Capital Management's PFE Position: Q2 2026 in Review
Osborne Partners Capital Management reduced its Pfizer (PFE) stake by 73% in Q2 2026, selling an estimated $2.08M and leaving 28,881 shares worth $695K. The position accounts for 0.04% of the portfolio, ranked #144.
Osborne Partners Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Osborne Partners Capital Management held 28,881 shares of Pfizer worth $695K as of Q2 2026.
- Osborne Partners Capital Management sold 79,700 Pfizer shares in Q2 2026, an estimated $2.08M.
- Pfizer made up 0.04% of Osborne Partners Capital Management's portfolio in Q2 2026, its #144 holding.
- Osborne Partners Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Osborne Partners Capital Management's Pfizer position peaked at $13.3M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.